One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The Lancet at 200: a start, but more to do
doi : 10.1016/S0140-6736(22)02586-7
Volume 401, Issue 10370, 7–13 January 2023, Page 1
Bimekizumab in psoriatic arthritis: a great leap forward?
doi : 10.1016/S0140-6736(22)02423-0
Volume 401, Issue 10370, 7–13 January 2023, Pages 2-3
Rezafungin and invasive candida infections: a new game changing antifungal?
doi : 10.1016/S0140-6736(22)02371-6
Volume 401, Issue 10370, 7–13 January 2023, Pages 3-5
Climate change, health, and discrimination: action towards racial justice
Thilagawathi Abi Deivanayagam, Sujitha Selvarajah, Jason Hickel, Renzo R Guinto, Priscila de Morais Sato, Jon Bonifacio, Sonora English, Mita Huq, Rita Issa, Hans Mulindwa, Heizal Patricia Nagginda, Chetna Sharma, Delan Devakumar
doi : 10.1016/S0140-6736(22)02182-1
Volume 401, Issue 10370, 7–13 January 2023, Pages 5-7
COVID-19 and other adult vaccines can drive global disease prevention
*David B Agus, Aurélia Nguyen, Amadou Alpha Sall, John Bell
doi : 10.1016/S0140-6736(22)02084-0
Volume 401, Issue 10370, 7–13 January 2023, Pages 8-10
The Lancet Commission on 21st-Century Global Health Threats
Natalia Kanem, *Christopher J L Murray, Richard Horton
doi : 10.1016/S0140-6736(22)02576-4
Volume 401, Issue 10370, 7–13 January 2023, Pages 10-11
Offline: Health's intercultural turn
Richard Horton
doi : 10.1016/S0140-6736(22)02594-6
Volume 401, Issue 10370, 7–13 January 2023, Page 12
Increasing humanitarian concerns for 2023
John Zarocostas
doi : 10.1016/S0140-6736(22)02587-9
Volume 401, Issue 10370, 7–13 January 2023, Pages 13-14
André Ilbawi: centring community-defined priorities in cancer care
Udani Samarasekera
doi : 10.1016/S0140-6736(22)02591-0
Volume 401, Issue 10370, 7–13 January 2023, Page 15
Advancing the commercial determinants of health agendaThe Commercial Determinants of Health, Nason Maani, Mark Petticrew, Sandro Galea (Eds.), Oxford University Press (2022), p. 416, £35·00, ISBN: 9780197578759 Simon Chapman, Quit Smoking: Weapons of Mass Distraction, Sydney University Press, AUS (2022), p. 380, $40·00, ISBN: 9781743328538
Kelley Lee
doi : 10.1016/S0140-6736(22)02578-8
Volume 401, Issue 10370, 7–13 January 2023, Pages 16-17
Unhealthy histories: sports and addictive sponsorship
*Anna Greenwood, Alex Mold, Heather Wardle
doi : 10.1016/S0140-6736(22)02579-X
Volume 401, Issue 10370, 7–13 January 2023, Pages 18-19
Eldryd Hugh Owen Parry
Geoff Watts
doi : 10.1016/S0140-6736(22)02580-6
Volume 401, Issue 10370, 7–13 January 2023, Page 20
Cardiovascular risk in systemic autoimmune diseases
Satoshi Funada, Yan Luo, Norihiro Nishioka, Takashi Yoshioka
doi : 10.1016/S0140-6736(22)02474-6
Volume 401, Issue 10370, 7–13 January 2023, Page 21
Cardiovascular risk in systemic autoimmune diseases
Giacomo Cafaro, Carlo Perricone, *Roberto Gerli, Elena Bartoloni
doi : 10.1016/S0140-6736(22)02477-1
Volume 401, Issue 10370, 7–13 January 2023, Pages 21-22
Cardiovascular risk in systemic autoimmune diseases – Authors' reply
Nathalie Conrad, *John J V McMurray
doi : 10.1016/S0140-6736(22)02426-6
Volume 401, Issue 10370, 7–13 January 2023, Page 22
Application of a sex-specific GRACE score in practice
Dorien M Kimenai, *Nicholas L Mills
doi : 10.1016/S0140-6736(22)02473-4
Volume 401, Issue 10370, 7–13 January 2023, Pages 22-23
Application of a sex-specific GRACE score in practice – Authors' reply
Florian A Wenzl, *Thomas F Lüscher
doi : 10.1016/S0140-6736(22)02457-6
Volume 401, Issue 10370, 7–13 January 2023, Page 23
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
Thomas Mulliez, *Mark De Ridder
doi : 10.1016/S0140-6736(22)02399-6
Volume 401, Issue 10370, 7–13 January 2023, Pages 23-24
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? – Authors' reply
Boon H Chua, Emma K Link, Ian H Kunkler, Ivo A Olivotto
doi : 10.1016/S0140-6736(22)02373-X
Volume 401, Issue 10370, 7–13 January 2023, Page 24
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
Iain B McInnes, Akihiko Asahina, Laura C Coates, Robert Landewé, Joseph F Merola, Christopher T Ritchlin, Yoshiya Tanaka, Laure Gossec, Alice B Gottlieb, Richard B Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Philip J Mease
doi : 10.1016/S0140-6736(22)02302-9
Volume 401, Issue 10370, 7–13 January 2023, Pages 25-37
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Joseph F Merola, Robert Landewé, Iain B McInnes, Philip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Alice B Gottlieb, Diamant Thaçi, Richard B Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C Coates
doi : 10.1016/S0140-6736(22)02303-0
Volume 401, Issue 10370, 7–13 January 2023, Pages 38-48
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
George R Thompson III, Alex Soriano, Oliver A Cornely, Bart Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Methee Chayakulkeeree, Ivan Poromanski, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas, on behalf of the ReSTORE trial investigators
doi : 10.1016/S0140-6736(22)02324-8
Volume 401, Issue 10370, 7–13 January 2023, Pages 49-59
Focusing on the eye signs of Alport syndrome in a 40-year-old man who previously had a kidney transplant and hearing loss
Bogdana Kovalchuk, Ramin Khoramnia
doi : 10.1016/S0140-6736(22)02401-1
Volume 401, Issue 10370, 7–13 January 2023, Page e1
Monkeypox
Oriol Mitjà , Dimie Ogoina, Boghuma K Titanji, Cristina Galvan, Jean-Jacques Muyembe, Michael Marks, Chloe M Orkin
doi : 10.1016/S0140-6736(22)02075-X
Volume 401, Issue 10370, 7–13 January 2023, Pages 60-74
The legacy of the COVID-19 pandemic for childhood vaccination in the USA
Douglas J Opel, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Richard M Carpiano, Chelsea Clinton, Jad A Elharake, Lisa C Flowers, Alison P Galvani, Peter J Hotez, Jason L Schwartz, Regina M Benjamin, Arthur Caplan, Renee DiResta, Rekha Lakshmanan, Yvonne A Maldonado, Michelle M Mello, Wendy E Parmet, Daniel A Salmon, Joshua M Sharfstein, Saad B Omer
doi : 10.1016/S0140-6736(22)01693-2
Volume 401, Issue 10370, 7–13 January 2023, Pages 75-78
